Haeggblom Linnea, Näsman Anders, Ramqvist Torbjörn, Haglund Caj, Hagström Jaana, Mäkitie Antti, Dalianis Tina
a Department of Oncology-Pathology , Karolinska Institute, CCK , Stockholm , Sweden.
b Department of Clinical Pathology, Cancer Center Karolinska , Karolinska Institute , Stockholm , Sweden.
Acta Otolaryngol. 2019 Feb;139(2):206-210. doi: 10.1080/00016489.2018.1552014. Epub 2019 Feb 22.
Human papillomavirus-positive (HPV) base of tongue squamous cell carcinoma (BOTSCC) has a better outcome than corresponding HPV cancer. TLR5 and TLR7 expression was previously shown to differ depending on HPV - status and correlate with outcome in oropharyngeal squamous cell carcinoma.
AIMS/OBJECTIVES: For validation, TLR5 and TLR7 were analyzed in a BOTSCC-cohort for correlation with HPV, survival, CD4 and CD8 tumor-infiltrating lymphocyte (TIL) counts, the latter being a well-documented prognostic marker.
BOTSCC biopsies, (49HPV/28HPV) were analyzed by immunohistochemistry for TLR5 and TLR7, and correlated with the above parameters.
TLR5 expression was more frequently absent/weak than medium/strong in HPV compared to HPV BOTSCC (p < .001). The opposite was observed for TLR7 (p < .007). TLR5 and TLR7 expression did not correlate to survival in either the HPV or HPV cases, or to CD4 TILs. TLR5, (but not TLR7) expression was correlated to CD8 TIL counts (p = .023).
Absent/weak TLR5 and medium/strong TLR7 expression was validated as more frequent in HPV compared with HPV BOTSCC. A correlation between CD8 TIL counts, and TLR5 expression was disclosed, but not with TLR7. Therefore, it could be useful to investigate TLR7 further as a potential independent prognostic marker.
人乳头瘤病毒阳性(HPV)的舌根鳞状细胞癌(BOTSCC)比相应的HPV阴性癌症预后更好。先前研究表明,Toll样受体5(TLR5)和Toll样受体7(TLR7)的表达因HPV状态而异,并且与口咽鳞状细胞癌的预后相关。
为进行验证,在一个BOTSCC队列中分析TLR5和TLR7,以研究其与HPV、生存率、CD4和CD8肿瘤浸润淋巴细胞(TIL)计数的相关性,后者是一个有充分文献记载的预后标志物。
通过免疫组织化学分析49例HPV阳性/28例HPV阴性的BOTSCC活检标本中的TLR5和TLR7,并将其与上述参数进行相关性分析。
与HPV阴性的BOTSCC相比,HPV阳性的BOTSCC中TLR5表达缺失/弱表达的情况比中等/强表达更为常见(p < 0.001)。TLR7的情况则相反(p < 0.007)。TLR5和TLR7的表达与HPV阳性或阴性病例的生存率均无相关性,与CD4 TILs也无相关性。TLR5(而非TLR7)的表达与CD8 TIL计数相关(p = 0.023)。
与HPV阴性的BOTSCC相比,HPV阳性的BOTSCC中TLR5表达缺失/弱表达及TLR7表达中等/强表达更为常见这一情况得到验证。研究发现CD8 TIL计数与TLR5表达相关,但与TLR7无关。因此,进一步研究TLR7作为潜在的独立预后标志物可能具有一定价值。